Richard H de Boer

Richard H de Boer

UNVERIFIED PROFILE

Are you Richard H de Boer?   Register this Author

Register author
Richard H de Boer

Richard H de Boer

Publications by authors named "Richard H de Boer"

Are you Richard H de Boer?   Register this Author

17Publications

373Reads

37Profile Views

Spotlight on the utility of the Oncotype DX breast cancer assay.

Int J Womens Health 2018 21;10:89-100. Epub 2018 Feb 21.

Department of Medical Oncology, Peter MacCallum Cancer Centre.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IJWH.S124520DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827461PMC
February 2018

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures.

Asia Pac J Clin Oncol 2017 Aug 10;13(4):266-276. Epub 2016 Nov 10.

Royal Melbourne and Epworth Hospitals, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12517DOI Listing
August 2017

Prevalence of excessive tearing in women with early breast cancer receiving adjuvant docetaxel-based chemotherapy.

J Clin Oncol 2013 Jun 6;31(17):2123-7. Epub 2013 May 6.

Curtin University and Mount Hospital, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.45.6574DOI Listing
June 2013

Does immediate breast reconstruction compromise the delivery of adjuvant chemotherapy?

Breast 2013 Feb 22;22(1):64-9. Epub 2012 Nov 22.

Department of Surgery, The University of Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2012.10.008DOI Listing
February 2013

Vandetanib in advanced non small cell lung cancer: a promise unfulfilled.

Transl Lung Cancer Res 2013 Feb;2(1):E7-9

Department of Medical Oncology, Royal Melbourne Hospital, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2012.11.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367652PMC
February 2013

Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer.

Onco Targets Ther 2013 3;6:1-7. Epub 2013 Jan 3.

Department of Oncology, Royal Melbourne Hospital, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S27671DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540909PMC
January 2013

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer.

Breast Cancer Res Treat 2012 Aug 29;135(1):241-52. Epub 2012 Jul 29.

Department of Medical Oncology, Royal Melbourne Hospital, Grattan St, 2nd Floor, Parkville, Melbourne, VIC 3050, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-012-2135-0
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2135-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413817PMC
August 2012

Vandetanib for the treatment of non-small-cell lung cancer.

Expert Opin Pharmacother 2011 Oct 6;12(14):2271-8. Epub 2011 Aug 6.

Royal Melbourne Hospital, Department of Medical Oncology, Grattan Street, Parkville, VIC 3050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2011.604634DOI Listing
October 2011

Use of non-anthracycline regimens in early stage breast cancer in Australia.

Asia Pac J Clin Oncol 2011 Mar 22;7(1):4-10. Epub 2010 Dec 22.

Department of Medical Oncology, Royal Melbourne Hospital, Parkville, Vic. 3050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-7563.2010.01353.xDOI Listing
March 2011